Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia [Phase 3]
A Phase 3 trial comparing the effectiveness and safety of risperidone versus haloperidol in patients with chronic schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients
This completed clinical trial evaluated how clinicians select antipsychotic treatment when switching medications in patients with schizophre…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis [NA]
A completed clinical trial comparing specialized addiction treatment versus treatment as usual for young patients with cannabis use disorder…
-
CLINICAL_TRIALS research · 2011-01-20Clinical Trial Update: Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating raloxifene for schizophrenia and schizoaffective disorder; the current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia [Phase 4]
Phase 4 trial evaluating Clozapine with Paliperidone versus Clozapine with placebo in resistant schizophrenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia [Phase 3]
Phase 3 study comparing the effectiveness and safety of injectable risperidone versus risperidone tablets in adults with chronic schizophren…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients [Phase 4]
Phase 4 trial evaluating risperidone in combination with lorazepam versus standard therapy for emergency treatment in schizophrenia; the stu…
-
FDA approval · 2011-01-11FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone filed by ANI Pharmaceuticals, Inc., indicating an update related to the product’…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls [Phase 4]
Phase 4 PET study assessing D2 receptor occupancy in relation to plasma levels of paliperidone ER and risperidone in schizophrenia patients …
-
CLINICAL_TRIALS research · 2011-01-11Clinical Trial Update: A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
A retrospective non-interventional study evaluated the real-world use of Seroquel XR and Seroquel IR in inpatients with schizophrenia; the s…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. [Phase 3]
A Phase 3 study evaluated the safety and tolerability of switching from oral antipsychotics to a long-acting injectable form of risperidone …
-
CLINICAL_TRIALS research · 2011-01-10Clinical Trial Update: Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
A completed non-interventional study sponsored by AstraZeneca evaluates the real-world efficacy and use of quetiapine for acute schizophreni…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
A completed non-interventional post-marketing surveillance study assessing safety and efficacy of Zeldox Capsule in bipolar disorder and sch…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS trial_result · 2010-12-29Clinical Trial Update: Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects [Phase 1]
A Phase 1 safety and tolerability study of HTC-867 in healthy Japanese volunteers has been completed. Schizophrenia is listed as the related…
-
CLINICAL_TRIALS trial_result · 2010-12-28Clinical Trial Update: Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia [NA]
Pilot study evaluating pregnenolone augmentation to address cognitive symptoms in persistently symptomatic patients with schizophrenia has c…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder [Phase 4]
Phase 4 trial update on the efficacy of quetiapine for patients with schizophrenia and comorbid substance use disorder; results were posted …
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits [Phase 2]
Phase 2 trial assessing armodafinil as add-on therapy for cognitive deficits in adults with schizophrenia; results on efficacy and safety we…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED) [Phase 2]
Merck completed a Phase 2 study (MK-5757-005) evaluating cognitive impairment in men with schizophrenia; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia [Phase 4]
Phase 4 trial evaluating pregnenolone augmentation in patients with recent-onset schizophrenia; the study status is completed, but no result…
-
CLINICAL_TRIALS research · 2010-12-15Clinical Trial Update: Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia
A clinical trial update evaluating the efficacy and safety of ziprasidone for depressive symptoms in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia [Phase 3]
Phase 3 study of lurasidone for acute schizophrenia has completed and results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment
This completed clinical trial evaluated changes in Clinical Global Impression (CGI) scores in schizophrenia patients treated with Seroquel X…
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment
This clinical trial update reports the completion of a Spanish validation of a questionnaire to assess patients' perceptions about antipsych…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program
The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.